Innovations in Pharma – Report Bundle (5 Reports)

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Innovations in Pharma Bundle Report Overview

The healthcare industry constantly demands innovation, improvement, accessibility, and affordability. The ‘Innovations in Pharma’ bundle highlights the emerging drug development technologies in providing quality healthcare services.

Accessing the in-depth insight from the Innovations in Pharma bundle can help you:

  • Make informed decisions about investments, partnerships, and product development
  • Understand your competitors’ strengths and weaknesses, identify areas of opportunity, and develop strategies to stay ahead in the market
  • Anticipate market changes and adjust your strategies accordingly
  • Develop risk management strategies and ensure business continuity

Innovations in Pharma bundle is a cost-effective solution as it provides access to multiple reports at a discounted price, compared to buying individual reports:

Click here to download sample pages of every report included in the Innovations in Pharma bundle

By purchasing the bundle worth $5,930 you can get access to a wealth of information and insights:

  • Market Insights and Trends –It provides in-depth insights of the current and future market trends, including macroeconomic trends and M&A trends. Additionally, it helps in identifying key areas of growth as well as ‘white-space’ opportunities and strategize accordingly.
  • Value Chain Analysis –It provides extensive value chain analysis comprising detailed insights across various stages of the value chain, which will help evaluation competitive positioning and identify key growth opportunities for drug discovery and development.
  • Pipeline Assessment –It provides comprehensive overview of the ongoing clinical trials in the specific therapy areas which will keep an eye on the competitors new product offerings.
  • Drug Development Scorecard –The scorecard helps to identify tomorrow’s leaders based on their competitive position in the most important themes impacting their industry.

We recommend this valuable source of information to anyone involved in:

  • ​Pharmaceutical/Biopharmaceutical Manufacturers
  • ​Clinical Research Organizations/ Contract manufacturing organizations
  • ​​Consultants
  • ​Investment Banksand ​PE/VC firms

Currently working in the pharma industry or those looking to enter this market as manufacturers, suppliers, consultants, PE/VC Firms, and investment banks.

Click here to download consolidated sample pages of reports in the Innovations in Pharma bundle

Report 1: State of the Biopharmaceutical Industry 2023

The biopharmaceutical industry is considered to be highly resistant to economic downturns and financial crisis, though not completely immune to it. Inflation, drug pricing and reimbursement constraints are anticipated to significantly impact the pharmaceutical industry in 2023. Genomics, real-world evidence (RWE), and immuno-oncology (IO) are some of the emerging industry trends that are likely to have the greatest impact on the pharmaceutical industry in 2023.​ For instance, when combined with ongoing advances in sequencing and data analyzing technologies, genomics has the potential to improve diagnosis speed and provide opportunities to personalize patient treatment approaches.

Top Emerging Pharmaceutical Industry Trends

Top Emerging Pharmaceutical Industry Trends

 

For more insights, Click here to download sample pages for the Innovations in Pharma Bundle

Report 2: Immuno-Oncology – Thematic Research

The field of immuno-oncology (IO) is consolidating its presence in most major types of cancer. Checkpoint modulation is the most valuable IO sector. Immuno-oncology therapeutics are transforming the treatment paradigms for patients with cancer. The development of novel drugs, biologics, and devices will lead to more effective therapies personalized to the unique immune biology within each cancer patient to stimulate and help the body’s natural defenses as a treatment for their cancer while minimizing toxicities.

Immuno-oncology Value Chain

Immuno-oncology Value Chain

 

For more insights, Click here to download sample pages for the Innovations in Pharma Bundle

Report 3: Microbiome-Targeting Therapeutics in Infectious Diseases – Thematic Research

Microbiome-targeting drugs aim to alter the microbial composition of the gut through the administration of live microbes (probiotics), or other compounds called prebiotics, to avoid administering live bacteria. Currently, only one successful microbiome-based intervention, fecal microbiota transplantation (FMT), is used in clinical practice to treat CDI. FMT involves the transfer of an entire microbial community from a healthy donor to an infected patient in order to replace the disease-associated microbiome. FMT has proven remarkable efficacy in treating CDI, which most commonly presents after antibiotic treatment.​ Ample opportunity remains for companies to invest in the microbiome space for a wide variety of infectious diseases indications, especially as antibiotic resistance continues to grow rapidly.​

For more insights, Click here to download sample pages for the Innovations in Pharma Bundle

Report 4: Neuroimmunology Drug Development – Thematic Research

The neuroimmune system is a complex system that plays an important role in regulating nervous system health and disease. Some of the key industry trends in neuroimmunology drug development include the application of similar mechanism of action (MOA) across numerous indications as well as the development of mAbs targeting pathogenic neural proteins in Alzheimer’s disease (AD) and Parkinson’s disease (PD), among others. The majority of marketed neuroimmunology products available in the 8MM target multiple sclerosis (MS). However, there have been approvals of these products in new indications in the recent years. Big pharma companies such as Roche, Biogen, AstraZeneca, Johnson & Johnson (J&J), Novartis, Sanofi, and UCB are all involved in marketing or developing neuroimmunology products across multiple neurological indications.​

Neuroimmunology Value Chain Select Key Targets and Therapy Types

Neuroimmunology Value Chain Select Key Targets and Therapy Types

For more insights, Click here to download sample pages for the Innovations in Pharma Bundle

Report 5: Gene Therapy in Oncology – Thematic Research

Gene therapies provide therapeutic benefits to patients, particularly those suffering from monogenic diseases. Gene therapies treat cancer by altering gene regulation in tumorigenic pathways and expressing genes in cells that cause them to be recognized as foreign or to elicit an immune response to tumorigenic cells. The market for gene therapies, particularly those based on viral vectors, is expected to be slowed by high therapy costs, which may limit their accessibility. Most gene therapy products for cancer are available in China followed by the five major European markets (5EU) (France, Germany, Italy, Spain, and the UK) and the US with one approved product. Existing regulatory programs facilitate the approval and development of gene therapies. However, novel reimbursement strategies are required to cover the high cost of gene therapies.

Gene Therapy Value Chain Analysis

Gene Therapy Value Chain Analysis

For more insights, Click here to download sample pages for the Innovations in Pharma Bundle

Report 1: State of the Biopharmaceutical Industry 2023




  • AstraZeneca

  • Novartis

  • Johnson & Johnson (J&J)

  • F Hoffman La Roche

  • Pfizer

  • Eli Lily

  • Merck


Report 2: Immuno-Oncology - Thematic Research




  • Novartis

  • Merck & Co

  • Gilead

  • Roche

  • Bristol-Myers Squibb

  • AstraZeneca

  • Sanofi

  • Amgen

  • Dendreon Pharmaceuticals

  • Legend Biotech


Report 3: Microbiome-Targeting Therapeutics in Infectious Diseases - Thematic Research




  • Rebiotix Inc

  • Nexbiome Therapeutics

  • Finch Therapeutics Group

  • Evelo Biosciences

  • Infant Bacterial Therapeutics

  • Osel Inc

  • Mikrobiomik Healthcare

  • Seres Therapeutics


Report 4: Neuroimmunology Drug Development – Thematic Research




Report 5: Gene Therapy in Oncology – Thematic Research




  • Amgen

  • SiBiono

  • Sunway Biotech

  • Candel

  • CG Oncology

  • Checkmate

  • Daiichi Sankyo


Table of Contents

Thematic Research: State of the Biopharmaceutical Industry 2023 

  1. Executive Summary: Brief Overview of the Biopharmaceutical industry in 2023
  2. Study Design: Provides study objectives and designs of the Biopharmaceutical industry
  3. Emerging Industry Trends: Highlights the top emerging trends in the Biopharmaceutical industry
  4. Emerging Regulatory and Macroeconomic Trends: Highlights major regulatory and macroeconomic trends associated with the Biopharmaceutical industry
  5. Emerging Technologies: Highlights the emerging technologies impacting the Biopharmaceutical industry
  6. Industry’s Growth Prospects: Provides details of the industry’s growth during the next 12 months
  7. Watch Outs: Market data and other insights related to the Biopharmaceutical industry
  8. Summary of Key Findings: Key findings related to the Biopharmaceutical industry
  9. Appendix 1
  10. Appendix 2
  11. Contact Us

Thematic Research: Immuno-Oncology

  1. Executive Summary – Brief overview of the Immuno-Oncology theme
  2. Immuno-oncology Overview – Definition and data related to Immuno-Oncology
  3. Trends – Major trends influencing the Immuno-Oncology theme
  4. Value Chain – Detailed information on the Immuno-Oncology value chain
  5. Marketed Products – Summary of marketed products in the Immuno-Oncology theme
  6. Pipeline Products – Details of products in the Immuno-Oncology pipeline
  7. Market Analysis – Data and insights related to Immuno-Oncology
  8. Regulatory and Market Access – Explanation of the key regulations in the Immuno-Oncology theme
  9. Opportunities, Challenges, and Unmet Needs – The key obstacles and opportunities for the growth of the Immuno-Oncology theme
  10. Companies – List of leading companies and their competitive positions in the Immuno-Oncology theme
  11. Appendix
  12. Contact Us

Thematic Research: Microbiome-Targeting Therapeutics in Infectious Diseases

  1. Executive Summary – Brief overview of the Microbiome-Targeting Therapeutics in infectious diseases theme
  2. Overview – Definition and data related to Microbiome and Microbiome-Targeting drugs
  3. Trends – Major trends influencing Microbiome-Targeting Therapeutics
  4. Value Chain – Detailed information on the Microbiome-Targeting Therapeutics value chain
  5. Current Therapies – Summary of Microbiome-Targeting drugs available at present
  6. Pipeline Products – Details of products in the Microbiome-Targeting Therapeutics pipeline
  7. Market Analysis – Data and insights related to Microbiome-Targeting Therapeutics
  8. Opportunities, Challenges, and Unmet Needs – The key obstacles and opportunities for the growth of Microbiome-Targeting Therapeutics
  9. Company Profiles – List of leading companies and their competitive positions in the Microbiome-Targeting Therapeutics
  10. Drug Development Thematic Scorecard – GlobalData’s scorecards highlighting the impact of the Microbiome-Targeting Therapeutics theme
  11. Appendix
  12. Contact Us

Neuroimmunology Drug Development – Thematic Research

  1. Executive Summary – Brief overview of neuroimmunology drugs
  2. Neuroimmunology Overview – Definition and other related details on neuroimmunology drugs
  3. Trends – Major trends influencing neuroimmunology drugs
  4. Value Chain – Detailed information on the neuroimmunology value chains
  5. Marketed Products – Summary of marketed neuroimmunology drugs
  6. Pipeline Products – Details of pipeline neuroimmunology products
  7. Clinical Trials – Details of clinical trials of neuroimmunology drugs
  8. Market Analysis – Data and insights related to neuroimmunology products
  9. Opportunities, Challenges, and Unmet Needs – The key obstacles and opportunities for the growth of neuroimmunology drugs
  10. Companies – List of companies in the neuroimmunology space
  11. Appendix
  12. Contact Us

Gene Therapy in Oncology – Thematic Research

  1. Executive Summary – Brief overview of the gene therapy sector
  2. Gene Therapy Overview – Definitions and other related details on gene therapies
  3. Trends – Highlights major industry and regulatory trends
  4. Value Chain – Detailed information on the gene therapy value chains
  5. Marketed Products – Details of marketed gene therapy products and treatments in the 8MM
  6. Pipeline Products – Details of gene therapy candidates in the 8MM
  7. Market Analysis and Deals – Data and insights related to gene therapy
  8. Regulatory and Market Access – Details of regulatory principles and market access associated with gene therapy
  9. Opportunities, Challenges, and Unmet Needs – The key obstacles and opportunities for the growth of gene therapies
  10. Companies – List of companies in the gene therapy market
  11. Appendix
  12. Contact Us

Frequently asked questions

Innovations in Pharma – Report Bundle (5 Reports) thematic reports
Currency USD
$2,950 $5,930 (50% off)

Can be used by individual purchaser only

$5,950 $8,930 (33% off)

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Innovations in Pharma – Report Bundle (5 Reports) was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Innovations in Pharma – Report Bundle (5 Reports) in real time.

  • Access a live Innovations in Pharma – Report Bundle (5 Reports) dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.